Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Ellis

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
Human Molecular Genetics|June 19, 2001
Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stabilityP Hu, S F Beresten, A J van Brabant, et al.
Genomics|July 1, 1996
Physical mapping of the bloom syndrome region by the identification of YAC and P1 clones from human chromosome 15 band q26.1J Straughen, S Ciocci, T Z Ye, et al.
Nature Genetics|November 1, 1994
PBDX is the XG blood group geneN A Ellis, P Tippett, A Petty, et al.
Cancer Research|March 23, 2000
Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cellsF B Johnson, D B Lombard, N F Neff, et al.
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
The Journal of Biological Chemistry|June 16, 2001
Functional interaction of p53 and BLM DNA helicase in apoptosisX W Wang, A Tseng, N A Ellis, et al.
Oncogene|October 14, 2000
Differential regulation of human RecQ family helicases in cell transformation and cell cycleT Kawabe, N Tsuyama, S Kitao, et al.
British Journal of Cancer|November 11, 2010
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsE Theodoratou, H Campbell, A Tenesa, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Human Molecular Genetics|June 19, 2001
Evidence for BLM and Topoisomerase IIIalpha interaction in genomic stabilityP Hu, S F Beresten, A J van Brabant, et al.
Genomics|July 1, 1996
Physical mapping of the bloom syndrome region by the identification of YAC and P1 clones from human chromosome 15 band q26.1J Straughen, S Ciocci, T Z Ye, et al.
Nature Genetics|November 1, 1994
PBDX is the XG blood group geneN A Ellis, P Tippett, A Petty, et al.
Cancer Research|March 23, 2000
Association of the Bloom syndrome protein with topoisomerase IIIalpha in somatic and meiotic cellsF B Johnson, D B Lombard, N F Neff, et al.
Journal of Medical Genetics|August 6, 2002
Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer familiesN D Kauff, P Perez-Segura, M E Robson, et al.
The Journal of Biological Chemistry|June 16, 2001
Functional interaction of p53 and BLM DNA helicase in apoptosisX W Wang, A Tseng, N A Ellis, et al.
Oncogene|October 14, 2000
Differential regulation of human RecQ family helicases in cell transformation and cell cycleT Kawabe, N Tsuyama, S Kitao, et al.
British Journal of Cancer|November 11, 2010
A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variantsE Theodoratou, H Campbell, A Tenesa, et al.
American Journal of Human Genetics|November 28, 2002
The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish populationW D Foulkes, I Thiffault, S B Gruber, et al.
Pageof 4